dc.contributor.author | Sharma, M | |
dc.contributor.author | Farquhar, C | |
dc.contributor.author | Ying, R | |
dc.contributor.author | Krakowiak, D | |
dc.contributor.author | Kinuthia, J | |
dc.contributor.author | Osoti, A | |
dc.contributor.author | Asila, V | |
dc.contributor.author | Gone, M | |
dc.contributor.author | Mark, J | |
dc.contributor.author | Barnabas, RV. | |
dc.date.accessioned | 2017-05-18T08:08:13Z | |
dc.date.available | 2017-05-18T08:08:13Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2:S174-80. doi: 10.1097/QAI.0000000000001057. | en_US |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/27355506 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113236/ | |
dc.identifier.uri | http://hdl.handle.net/11295/100954 | |
dc.description.abstract | INTRODUCTION:
Women in sub-Saharan Africa face a 2-fold higher risk of HIV acquisition during pregnancy and postpartum and the majority do not know the HIV status of their male partner. Home-based couple HIV testing for pregnant women can reduce HIV transmission to women and infants while increasing antiretroviral therapy (ART) coverage in men. However, the cost-effectiveness of this program has not been evaluated.
METHODS:
We modeled the health and economic impact of implementing a home-based partner education and HIV testing (HOPE) intervention for pregnant women and their male partners in a region of Western Kenya (formally Nyanza Province). We used data from the HOPE randomized clinical trial conducted in Kisumu, Kenya, to parameterize a mathematical model of HIV transmission. We conducted an in-country microcosting of the HOPE intervention (payer perspective) to estimate program costs as well as a lower cost scenario of task-shifting to community health workers.
RESULTS:
The incremental cost of adding the HOPE intervention to standard antenatal care was $31-37 and $14-16 USD per couple tested with program and task-shifting costs, respectively. At 60% coverage of male partners, HOPE was projected to avert 6987 HIV infections and 2603 deaths in Nyanza province over 10 years with an incremental cost-effectiveness ratio (ICER) of $886 and $615 per disability-adjusted life year averted for the program and task-shifting scenario, respectively. ICERs were robust to changes in intervention coverage, effectiveness, and ART initiation and dropout rates.
CONCLUSIONS:
The HOPE intervention can moderately decrease HIV-associated morbidity and mortality by increasing ART coverage in male partners of pregnant women. ICERs fall below Kenya's per capita gross domestic product ($1358) and are therefore considered cost-effective. Task-shifting to community health workers can increase intervention affordability and feasibility. | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.title | Modeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya. | en_US |
dc.type | Article | en_US |